news-med.jpg

Evotec Receives Clinical Milestone as Part of its Discovery Alliance with Boehringer Ingelheim

ACHIEVEMENT MARKS 24TH MILESTONE UNDER ALLIANCE TO DATE Hamburg, Germany, 01 December 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that it has achieved a clinical milestone under its drug discovery alliance with Boehringer Ingelheim triggering revenues ...

Topics: Corporate, Business, Drug Discovery, Contract Reseach Organization, Respiratory Read More